Akkermansia muciniphila

N/A

Report date: 2024/01/12 20:08:48

Base Information

Drug NameAkkermansia muciniphila
Drug Alias NameLive Bacterial Product - Akkermansia muciniphilaOncobax-AKAkkermansia p2261 strain
ClassificationBiologics > Live Biotherapeutic
Mechanisms of ActionBacteria replacements
TargetsNot applicable
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungCarcinoma, Renal Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumFrance
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEverImmune
China Registration ClassN/A

Develop Information

Active CompaniesEverImmune
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell LungCarcinoma, Renal Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A